Back to Search Start Over

Diagnostic Ability of Magnifying Blue Light Imaging with a Light Emitting Diode Light Source for Early Gastric Cancer: A Prospective Comparative Study.

Authors :
Takayama, Shun
Dohi, Osamu
Naito, Yuji
Azuma, Yuka
Ishida, Tsugitaka
Kitae, Hiroaki
Matsumura, Shinya
Ogita, Kazuyuki
Mizuno, Naoki
Terasaki, Kei
Nakano, Takahiro
Ueda, Tomohiro
Morinaga, Yukiko
Hirose, Ryohei
Inoue, Ken
Yoshida, Naohisa
Kamada, Kazuhiro
Uchiyama, Kazuhiko
Ishikawa, Takeshi
Takagi, Tomohisa
Source :
Digestion; 2021, Vol. 102 Issue 5, p580-589, 10p
Publication Year :
2021

Abstract

Introduction: An innovative endoscopic system using 4-color light-emitting diodes (LED) was released between 2016 and 2017 in locations that had not approved laser endoscopes for use, including the United States and Europe. Objective: This study compared the diagnostic efficacy between magnifying blue light imaging with an LED light source (LED-BLI) and magnifying blue laser imaging with a laser light source (Laser-BLI) for early gastric cancer (EGC). Methods: In this prospective, single-center, noninferiority study, 80 gastric lesions were evaluated between January 2017 and July 2017. The magnifying findings of gastric lesions – including the demarcation line (DL), microvascular pattern (MVP), and microsurface pattern (MSP) – were evaluated using Laser-BLI and LED-BLI according to the vessel plus surface classification system (VSCS). The primary end point was to determine whether the diagnostic accuracy of LED-BLI for EGC was noninferior to that of conventional Laser-BLI. Results: Overall, we evaluated 79 gastric lesions histopathologically diagnosed as adenocarcinomas from the specimens obtained via endoscopic submucosal dissection. A DL was observed by Laser-BLI and LED-BLI in 98.7% (78/79) and 96.2% (76/79) of EGCs, respectively. The MVP observed using Laser-BLI and LED-BLI was irregular in 92.4% (73/79) and 89.9% (71/79), respectively. The MSP observed using Laser-BLI and LED-BLI was irregular in 83.5% (66/79) and 82.2% (65/79), respectively. According to the VSCS, diagnosable cancers were found in 94.9% (75/79) and 93.7% (74/79) of cases when using Laser-BLI and LED-BLI, respectively (p = 0.73; difference ratio, 1.2%; 95% CI –8.5 to 6.0%). Conclusions: LED-BLI could accurately visualize the DL, MVP, and MSP of EGCs and was not inferior to Laser-BLI. Therefore, LED-BLI can be used to diagnose EGC accurately according to the VSCS-based diagnosis criteria. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00122823
Volume :
102
Issue :
5
Database :
Complementary Index
Journal :
Digestion
Publication Type :
Academic Journal
Accession number :
151195387
Full Text :
https://doi.org/10.1159/000505018